Updating results

895 results for Women's health

Sort: Date | Relevance

In women with confirmed miscarriage, does the type of management strategy (expectant, medical and surgical) impact on women's experience, including psychological and emotional outcomes?

Question In women with confirmed miscarriage, does the type of management strategy (expectant, medical and surgical) impact on...

Research recommendation Published August 2019

Is obesity an independent risk factor for perinatal morbidity and mortality?

fetal heart rate, uterine contractions and fetal position in women who are obese. These women are likely to have more...

Research recommendation Published August 2019

Prevention and control of healthcare-associated infections

Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart

NICE Pathway Published March 2012 Last updated August 2019

Endorsement

Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.

Published August 2019 Last updated August 2019

Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA595)

Evidence-based recommendations on dacomitinib (Vizimpro) for locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (NSCLC) in adults

Technology appraisal guidance Published August 2019

Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (TA593)

Evidence-based recommendations on ribociclib (Kisqali) for hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer in adults

Technology appraisal guidance Published August 2019

Venous thromboembolism

Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Advanced breast cancer

Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Endocrine, nutritional and metabolic conditions

Everything NICE has said on endocrine, nutritional and metabolic conditions in an interactive flowchart

NICE Pathway Published December 2014 Last updated August 2019

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)

This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots) and deep vein thrombosis (DVT) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.

NICE guideline Published March 2018 Last updated August 2019

Smoking

Everything NICE has said on preventing the uptake of smoking and helping people to stop smoking in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Chronic obstructive pulmonary disease

Everything NICE has said on diagnosing and managing chronic obstructive pulmonary disease in people aged 16 and over in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Committee D members

Find out more about NICE technology appraisals advisory committee D members

Published August 2019 Last updated August 2019

Diagnostics Advisory Committee members

Chair Consultant in Public Health Medicine, PHG Foundation About Mark Mark Kroese is a Consultant in Public Health Medicine...

Published August 2019 Last updated August 2019

NICE recommends additional treatment option for people with early breast cancer

NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.

News Published August 2019 Last updated August 2019

Crohn's disease

Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart

NICE Pathway Published October 2012 Last updated August 2019

Being monitored and out of remit procedures

Clinician Cervical Ripening Ballon for the Induction of Labour in Pregnant Women GYNAECOLOGY, PREGNANCY AND BIRTH Minor modification of...

Published August 2019 Last updated August 2019

Preterm labour and birth

Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart

NICE Pathway Published November 2015 Last updated August 2019

Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis (TA590)

Evidence-based recommendations on fluocinolone acetonide intravitreal implant (Iluvien) for treating recurrent non-infectious uveitis in adults

Technology appraisal guidance Published July 2019

Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund

Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.

News Published July 2019 Last updated July 2019

Multiple sclerosis in adults: management (CG186)

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.

Clinical guideline Published October 2014 Last updated July 2019

Block scoping reports

This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

Published July 2019 Last updated July 2019

Urinary incontinence and pelvic organ prolapse in women

Everything NICE has said about managing urinary incontinence and pelvic organ prolapse in women in an interactive flowchart

NICE Pathway Published September 2013 Last updated July 2019

Chronic kidney disease

Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

NICE Pathway Published May 2011 Last updated July 2019

Antenatal care for uncomplicated pregnancies

Everything NICE has said on antenatal care for healthy women with uncomplicated pregnancies in an interactive flowchart

NICE Pathway Published November 2011 Last updated July 2019

Heavy menstrual bleeding

Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

NICE Pathway Published February 2012 Last updated July 2019

Hypertension in pregnancy

Everything NICE has said on diagnosing and managing hypertension in pregnancy in an interactive flowchart

NICE Pathway Published August 2013 Last updated July 2019

Hypertension in pregnancy (QS35)

This quality standard covers diagnosing and managing hypertension (high blood pressure) and pre-eclampsia during pregnancy, labour and birth. It also covers advice for women with hypertension who may become pregnant and postnatal care for women who have had hypertension or pre-eclampsia. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2013 Last updated July 2019

Motor neurone disease: assessment and management (NG42)

This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

NICE guideline Published February 2016 Last updated July 2019

Neuropathic pain

Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

NICE Pathway Published November 2013 Last updated July 2019

Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)

This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.

Clinical guideline Published November 2013 Last updated July 2019

Breast cancer patients to have further NICE-approved drug combination option on Cancer Drugs Fund

Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (17 July 2019).

News Published July 2019 Last updated July 2019

Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis

Diagnostics guidance Published July 2019

Lyme disease

Everything NICE has said on diagnosing and managing Lyme disease in an interactive flowchart

NICE Pathway Published April 2018 Last updated July 2019

Health of people in the criminal justice system

Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system

NICE Pathway Published November 2016 Last updated July 2019

Bisphosphonates for treating osteoporosis (TA464)

Evidence-based recommendations on bisphosphonates (alendronic acid; ibandronic acid; risedronate sodium; zoledronic acid) for treating osteoporosis in adults

Technology appraisal guidance Published August 2017 Last updated July 2019

Urinary tract infections

Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

NICE Pathway Published August 2012 Last updated July 2019

Appeal panel membership

in the life sciences industry for 30 years. His career has spanned global health technology companies across Europe and North America,...

Published July 2019 Last updated July 2019

Child abuse and neglect

Everything NICE has said on child abuse and neglect in an interactive flowchart

NICE Pathway Published October 2017 Last updated July 2019

Familial hypercholesterolaemia

Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart

NICE Pathway Published August 2013 Last updated July 2019

Postnatal care

Everything NICE has said on the essential care that every woman and her baby should receive in the first 6–8 weeks after birth in an interactive flowchart

NICE Pathway Published May 2011 Last updated July 2019

Contraception

Everything NICE has said on contraceptive services, long-acting reversible contraception and sterilisation in an interactive flowchart

NICE Pathway Published March 2014 Last updated July 2019

Contraceptive services for under 25s

Everything NICE has said on contraceptive services for under 25s in an interactive flowchart

NICE Pathway Published March 2014 Last updated July 2019

Long-acting reversible contraception (CG30)

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

Clinical guideline Published October 2005 Last updated July 2019

Keep homes well ventilated when cooking and cleaning to prevent ill health

NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.

News Published June 2019 Last updated June 2019

Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality (TA322)

Evidence-based recommendations on lenalidomide (Revlimid) for myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

Technology appraisal guidance Published September 2014 Last updated June 2019